Combination Antiretroviral Therapy (cART) Component Ritonavir Significantly Alters Docetaxel Exposure

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2399-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search